Key result
COVID-19 pandemic ACS management favors conservative strategies in severe pneumonia and monitoring drug interactions.
Why the study?
Well-defined algorithms and guidelines were lacking for managing ACS during the COVID-19 pandemic, leading to variable treatment across countries and unresolved questions regarding routing, therapy, and drug interactions.
Provides early pandemic clinical and organizational guidance for managing acute coronary syndrome in the setting of COVID-19 to protect healthcare workers and optimize patient triage.
Supports conservative ACS strategies in severe COVID-19 pneumonia with interaction monitoring; leaves open standardized protocols pending prospective data.
The novel coronavirus infection COVID-19 pandemic has spread to more than 180 countries. Cardiovascular patients belong to one of the susceptible population cohorts. There is a peculiar pathogenesis and variety of clinical manifestations of COVID-19, as well as difficulties with early diagnosis. Other unresolved issues are routing, surgery and therapy of such patients and comorbidities. Due to absence of well-defined algorithms and guidelines, the treatment of patients with acute coronary syndrome (ACS) in different countries is carried out differently. Interactions between antiviral and coronary artery disease medications are also not completely clear. Based on the available data, the main organizational and therapeutic approaches for ACS during the COVID-19 pandemic are reflected.
No takes yet. Share an insight, caveat, or question.
Намитоков et al. (2020) conducted a review in Acute coronary syndrome and COVID-19. Organizational and therapeutic approaches for ACS during COVID-19 was evaluated. Organizational and therapeutic approaches for managing acute coronary syndrome during the COVID-19 pandemic emphasize conservative strategies for severe pneumonia patients and careful monitoring of drug interactions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: